We need to keep supporting this kind of research,” a Connecticut researcher and doctor said. “To see if we replicate these ...
In a groundbreaking early-phase trial, a personalized vaccine triggered a powerful immune response in nine patients with advanced kidney cancer, successfully wiping out the disease and keeping it ...
The retired NBA pro, who was diagnosed with kidney cancer at age 41, wants to give hope to others undergoing health challenges.
A simple urine test could accurately show the recurrence of kidney cancer at an early stage, potentially sparing patients invasive scans and enabling faster access to treatment, new research has shown ...
According to him, advanced kidney cancer is reasonably common with about 85,000 people diagnosed in the United States each year. His trial focused on nine patients who received a PCV designed to ...